NASDAQ · Drug Manufacturers - Specialty & Generic

SXTC (SXTC) Stock

$0.07 +9.40% NASDAQ: SXTC Healthcare

Valuation

MetricValue
Price$0.07
Market Cap$47453
P/E Ratio-0.20
P/B Ratio0.08
P/S Ratio1.36
EPS (TTM)$-8.18
52-Week High$1047.00
52-Week Low$0.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-20.00%
ROA-13.64%
ROCE-18.75%
Gross Margin-100.00%
Operating Margin-150.00%
Net Margin-2.74%
Debt/Equity0.06
Current Ratio3.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$5.0M$3.0M$2.0M$2.0M$2.0M
Operating Profit$-2.0M$-5.0M$-6.0M$-3.0M$-3.0M
Net Profit$-3.0M$-6.0M$-6.0M$-3.0M$-3.0M
EPS$-95.48$-137.92$-22.23$-3.57$-8.18
Op Margin-46.0%-199.4%-284.4%-130.4%-154.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$35.0M$34.0M$30.0M$23.0M$22.0M
Total Liabilities$19.0M$17.0M$15.0M$9.0M$6.0M
Cash$13.0M$16.0M$17.0M$12.0M$18.0M
Borrowings$0$2.0M$4.0M$3.0M$1.0M

Latest News

China Sxt Pharmaceuticals Files Resale Registration for Up to 157.5 Million Shares MT Newswires · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$0$0$-2.0M$-2.0M
Investing Cash Flow$-6.0M$0$0$0$0
Financing Cash Flow$13.0M$-1.0M$-3.0M$-4.0M$6.0M
Net Cash Flow$6.0M$2.0M$2.0M$-5.0M$6.0M
Free Cash Flow$-1.0M$0$0$-2.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-80.00%
Quick Ratio4.24
Interest Coverage-3.00
Return 1Y-98.97%
Return 3Y-99.65%
Return 5Y-99.97%

Ownership

Insiders Held109.48%
Institutions Held0.24%
Institutions Float Held-2.56%
Institutional HolderSharesReport Date
Sabby Management, LLC78,1702026-03-31
UBS Group AG12026-03-31
Caitong International Asset Management Co., Ltd12026-03-31
Royal Bank of Canada132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATLN $0.90 +0.00% -1.31 $73.17M 0.00%
AVR $8.28 +0.00% -2.56 $304.61M 0.00%
CYBNCybin Inc. $8.28 +1.22% -1.67 $413.02M 0.00%
FATE $2.31 -0.43% -1.62 $269.25M 0.00%
IPHAInnate Pharma S.A. $1.79 +0.14% -2.89 $168.32M 0.00%

About SXTC

SXTC is led by CEO Feng Zhou, publicly traded since 2019.

SXTC stock trades at $0.07 with a market capitalization of $47453. The stock is valued at a price-to-earnings (P/E) ratio of -0.20, price-to-book of 0.08, price-to-sales of 1.36. Over the past 52 weeks the stock has ranged between $0.06 and $1047.00, and currently trades 100.0% below its 52-week high.

On profitability, SXTC generates a return on equity (ROE) of -20.00%, return on capital employed of -18.75%, an operating margin of -150.00%, a net profit margin of -2.74%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides